Burcon to Present at 6th Annual LD MICRO Conference on

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Burcon to Present at 6th Annual LD MICRO Conference on December 5

VANCOUVER, British Columbia, Nov. 20, 2013 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (Nasdaq: BUR ) , a leader in developing functionally superior plant-based proteins, has been invited to present at LD MICRO's 6th Annual Conference. The conference will be held at the Luxe Hotel in Los Angeles on December 3-5, 2013.

Burcon management is scheduled to present on Thursday, December 5 at 3:00 p.m. Pacific time, with one-on-one meetings held throughout the day.

Management will discuss the company's progress, including the commercial rollout of its award-winning CLARISOY™ soy protein and the introduction of Peazazz™, a revolutionary protein derived from field peas.

The company's unique plant protein extraction technology, which is supported by key U.S. patents, has propelled Burcon into an industry-leading position as a developer of premium plant protein ingredients that demonstrate exceptional clarity, solubility, clean taste, sustainability, manufacturing scalability and value for a growing demographic of health-conscious consumers.

For additional information about the LD MICRO Conference, visit www.ldmicro.com .

About Burcon NutraScience Corporation

Burcon NutraScience is a leader developing functionally superior plant-based proteins. The company has developed a portfolio of composition, application, and process patents originating from a core protein extraction and purification technology. Burcon's CLARISOY™ soy protein offers clarity and high-quality protein nutrition for low pH beverage systems; Peazazz® is a uniquely soluble and clean-tasting pea protein; and Puratein®, Supertein™ and Nutratein® are canola protein isolates with unique functional and nutritional attributes. For more information about the company, visit www.burcon.ca .

ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President and Chief Operating Officer

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements, including, without limitation, statements regarding plans and timing for the introduction or enhancement of our products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the actual results of marketing activities, adverse general economic, market or business conditions, regulatory changes and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form dated June 25, 2013. Any forward-looking statement or information only speaks as of the date on which it was made and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such.

CLARISOY is a trademark of Archer Daniels Midland Company.

Media & Industry Contact: Michael Kirwan Director, Corporate Development Burcon NutraScience Corporation Tel (604) 733-0896, Toll-free (888) 408-7960 Investor Relations Contact: Matt Glover or Michael Koehler Liolios Group Inc. Tel (949) 574-3860

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 2

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 6

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Ama La Vida's New Coaching: More Than a Financial Plan

Updated Category News Views 0

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 2

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 2

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 3

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 67

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Samsung Partners with AI Innovators for Galaxy S26 Launch

Updated Category News Views 234

Samsung’s Ambitious AI Integration for Galaxy S26 Samsung Electronics SSNLF is actively pursuing partnerships with OpenAI and Perplexity AI as it strives to incorporate a wider array of artificial intelligence capabilities into its next-generation Galaxy devices. The company's intent is to diversify its AI services, significantly reducing its previous dependency on...

Continue Reading
Orion Corporation's Recent Share Transactions by Eija Ronkainen

Updated Category News Views 151

Overview of Managers' Transactions at Orion Corporation Orion Corporation is committed to transparency and accountability in its operations. Recently, a disclosure was made concerning share transactions involving Eija Ronkainen, a notable member of the company's Board. This transaction is governed by the Market Abuse Regulation (EU) No 596/2014. Details of the Disclosure...

Continue Reading
Essity Reports Strong Performance Amid Economic Challenges

Updated Category News Views 215

Continuous Growth and Resilience in Tough Times Essity's recent interim report for the second quarter of 2025 showcases the company's ability to navigate through economic headwinds while maintaining a focus on growth and innovation. Even with a challenging economic backdrop, Essity demonstrated a stronger financial performance, indicating a commitment to both its...

Continue Reading
Lantheus Holdings Faces Class Action Lawsuit from Shareholders

Updated Category News Views 132

Lantheus Holdings and the Class Action Lawsuit Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently embroiled in a securities fraud class action lawsuit that has garnered attention from investors. This development comes after a shareholder filed a suit on behalf of those who acquired shares of the company between specific dates in 2025. Details of the Lawsuit The lawsuit...

Continue Reading
Ménage à Trois Introduces New Low-Calorie White Wine

Updated Category News Views 154

Ménage à Trois Introduces Light Sauvignon Blanc Fresh and flavorful, the Light Sauvignon Blanc from Ménage à Trois is set to delight consumers while catering to the growing demand for low-alcohol wines. With only 90 calories and 8% alcohol by volume, this new addition reflects the brand's commitment to providing products that align with modern lifestyles. Expanding...

Continue Reading